Search for Clinical Trial Results
Hypogonadism - 37 Studies Found
Status | Study |
Completed |
Study Name: Testogel® (Testosterone Gel 50mg/5g) in the Treatment of Male Hypogonadism Condition: Hypogonadism Date: 2013-02-06 Interventions:
|
Recruiting |
Study Name: Study to Compare DITEST to Testosterone Undecanoate in Adult Men With Hypogonadism Condition: Male Hypogonadism Date: 2016-09-26 Interventions:
|
Completed |
Study Name: Effects on the Brain of Lupron Induced Hypogonadotropic Hypogonadism With and Without Testosterone Replacement Condition: Hypogonadism Date: 1999-11-03 |
Completed |
Study Name: The Effect of Testosteron Replacement Treatment on the Fibroblast Growth Factor-23, Asymmetric Dimethylarginine and Vitamin D Levels in the Congenital Hypogonadotropic Hypogonadism Condition: Hypogonadism Date: 2014-04-07 Interventions: Drug: Testosterone Testosterone 250 mg injection per 3-4 weeks for 6 months |
Completed |
Study Name: Leuprolide in Treating Adults With Hypogonadotropism Condition: Hypogonadism Date: 1999-10-18 Interventions: Drug: leuprolide |
Terminated |
Study Name: A Phase 2a Pharmacodynamic Study of TAK-448 in Participants With Hypogonadotropic Hypogonadism Condition: Hypogonadotropic Hypogonadism Date: 2015-02-17 Interventions: Drug: TAK-448 TAK-448 solution for subcutaneous injection |
Completed |
Study Name: To Evaluate Sperm Parameters in Men With Secondary Hypogonadism Previously Treated With Topical Testosterone Condition: Secondary Hypogonadism Date: 2008-06-25 Interventions:
|
Completed |
Study Name: A Study of the Efficacy and Safety of Corifollitropin Alfa (MK-8962) in Combination With Human Chorionic Gonadotropin (hCG) in Adult Men With Hypogonadotropic Hypogonadism (HH) (P07937) Condition:
|
Completed |
Study Name: Visceral Adiposity Index and Triglyceride/High-density Lipoprotein Cholesterol Ratio in the Congenital Hypogonadotropic Hypogonadism and Effect of Testosteron Treatment Condition: Hypogonadism Date: 2014-04-05 Interventions: Drug: Testosterone Testosterone 250 mg injection per 3-4 weeks for 6 months |
Recruiting |
Study Name: Efficacy and Safety of Corifollitropin Alfa (MK-8962) in Combination With Human Chorionic Gonadotropin (hCG) in Adolescent Males With Hypogonadotropic Hypogonadism (HH) Condition: Hypogonadotropic Hypogonadism Date: 2017-01-11 Interventions:
|